TMEM106A transcriptionally regulated by promoter methylation is involved in invasion and metastasis of hepatocellular carcinoma

TMEM106A transcriptionally regulated by promoter methylation is involved in invasion and metastasis of hepatocellular carcinoma

Expression of transmembrane protein 106A (TMEM106A) has been reported to be dysregulated in several types of cancers. However, the role of TMEM106A in hepatocellular carcinoma (HCC) is still unknown. In the present study, we demonstrate that TMEM106A is markedly downregulated in HCC compared with no...

Full description

Bibliographic Details
Main Authors:	Shi Shiming, Wang Biao, Wan Jinglei, Song Lina, Zhu Guiqi, Du Junxian, Ye Luxi, Zhao Qianqian, Cai Jialiang, Chen Qing, Xiao Kun, He Jian, Yu Lei, Dai Zhi
Format:	Article
Language:	English
Published:	China Science Publishing & Media Ltd. 2022-06-01
Series:	Acta Biochimica et Biophysica Sinica
Subjects:	hepatocellular carcinoma transmembrane protein 106A methylation epithelial mesenchymal transition metastasis
Online Access:	https://www.sciengine.com/doi/10.3724/abbs.2022069

Similar Items

The identification of high-performing antibodies for transmembrane protein 106B (TMEM106B) for use in Western blot, immunoprecipitation, and immunofluorescence [version 1; peer review: 1 approved, 2 approved with reservations]
by: Peter S. McPherson, et al.
Published: (2023-03-01)

TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer
by: Yung-Fu Chang, et al.
Published: (2023-05-01)

The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus
by: Jun Yup Lee, et al.
Published: (2023-09-01)

TMEM106B aggregation in neurodegenerative diseases: linking genetics to function
by: Hai-Shan Jiao, et al.
Published: (2023-08-01)

Characterization of the Clinical Significance and Immunological Landscapes of a Novel TMEMs Signature in Hepatocellular Carcinoma and the Contribution of TMEM201 to Hepatocarcinogenesis
by: Desheng Chen, et al.
Published: (2023-06-01)

Identification of a de novo Mutation in TMEM106B in a Saudi Child Causes Hypomyelination Leukodystrophy
by: Lena Alotaibi, et al.
Published: (2023-01-01)

Variation in TMEM106B in chronic traumatic encephalopathy
by: Jonathan D. Cherry, et al.
Published: (2018-11-01)

Antibody-recognizing residues 188-211 of TMEM106B exhibit immunohistochemical reactivity with the TMEM106B C-terminal fragment
by: Ruoyi Ishikawa, et al.
Published: (2023-10-01)

TMEM106a is a Novel Tumor Suppressor in Human Renal Cancer
by: Chenglong Wu, et al.
Published: (2017-10-01)

Estimativas de doses relativas de aplicadores esféricos de 106Ru/106Rh usados em braquiterapia oftalmológica
by: Eduardo De Paiva
Published: (2016-09-01)

Data on estimations of relative dose rates along central axis of symmetric and asymmetric 106Ru/106Rh applicators used in eye brachytherapy
by: Eduardo De Paiva
Published: (2021-02-01)

Lack of a protective effect of the Tmem106b “protective SNP” in the Grn knockout mouse model for frontotemporal lobar degeneration
by: Anne-Sophie Cabron, et al.
Published: (2023-01-01)

Determinação da Distribuição de Dose Absorvida na Água para o Aplicador Oftálmico COC de 106Ru/106Rh Utilizando o Código de Monte Carlo-MCNPX
by: nilseia aparecida barbosa
Published: (2015-05-01)

Methyl Gallate Suppresses the Migration, Invasion, and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells via the AMPK/NF-κB Signaling Pathway in vitro and in vivo
by: Huaguo Liang, et al.
Published: (2022-06-01)

Case report: TMEM106B haplotype alters penetrance of GRN mutation in frontotemporal dementia family
by: Jolien Perneel, et al.
Published: (2023-04-01)

Numerical calculation of relative dose rates from spherical 106Ru beta sources used in ophthalmic brachytherapy
by: Eduardo de Paiva
Published: (2015-01-01)

Radioactive dust with 106Ru over the southern region of Ukraine
by: Yu. A. Tomilin, et al.
Published: (2018-09-01)

Loss of TMEM106B exacerbates C9ALS/FTD DPR pathology by disrupting autophagosome maturation
by: Claudia S. Bauer, et al.
Published: (2022-12-01)

CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia
by: Shihong Lu, et al.
Published: (2017-08-01)

Theoretical estimate of relative depth-doses for the asymmetric and spherical 106Ru/106Rh COC-type plaque used in radiotherapy
by: Eduardo De Paiva
Published: (2020-03-01)

TMEM106B haplotypes have distinct gene expression patterns in aged brain
by: Yingxue Ren, et al.
Published: (2018-07-01)

Mechanism of miR‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cells
by: Hong‐Cheng Lv, et al.
Published: (2022-04-01)

TMEM63C, a Potential Novel Target for Albuminuria Development, Is Regulated by MicroRNA-564 and Transforming Growth Factor beta in Human Renal Cells
by: Miriam Orphal, et al.
Published: (2020-10-01)

<i>TMEM106B</i> Acts as a Modifier of Cognitive and Motor Functions in Amyotrophic Lateral Sclerosis
by: Arianna Manini, et al.
Published: (2022-08-01)

rs1990622 variant associates with Alzheimer’s disease and regulates TMEM106B expression in human brain tissues
by: Yang Hu, et al.
Published: (2021-01-01)

The TMEM106B T186S coding variant increases neurite arborization and synaptic density in primary hippocampal neurons
by: Quynh Nguyen, et al.
Published: (2023-10-01)

Penerapan PSAK No. 106 Pada Pembiayaan Musyarakah di BMT Batik Mataram
by: Andreani Hanjani, et al.
Published: (2019-10-01)

Borealin Promotes Tumor Growth and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma
by: Chen B, et al.
Published: (2022-03-01)

Exploring the Mechanism of Flaccidoxide-13-Acetate in Suppressing Cell Metastasis of Hepatocellular Carcinoma
by: Yu-Jen Wu, et al.
Published: (2020-06-01)

IL‐17A promotes the invasion–metastasis cascade via the AKT pathway in hepatocellular carcinoma
by: Qing‐guo Xu, et al.
Published: (2018-06-01)

Histone Deacetylases Inhibit the Snail2-Mediated EMT During Metastasis of Hepatocellular Carcinoma Cells
by: Yue Hu, et al.
Published: (2020-08-01)

Type I Interferon-Induced TMEM106A Blocks Attachment of EV-A71 Virus by Interacting With the Membrane Protein SCARB2
by: Xuemin Guo, et al.
Published: (2022-03-01)

Role of IQGAP3 in metastasis and epithelial–mesenchymal transition in human hepatocellular carcinoma
by: Yongjie Shi, et al.
Published: (2017-08-01)

KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3
by: Yanhong Wang, et al.
Published: (2021-12-01)

Analisis Penerapan Akuntansi Musyarakah terhadap PSAK 106 pada Bank Syariah X
by: Muhammad Yusuf
Published: (2012-05-01)

Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition
by: Yuan Zhou, et al.

DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma
by: Jin Chen, et al.
Published: (2019-06-01)

TMEM106B Puncta Is Increased in Multiple Sclerosis Plaques, and Reduced Protein in Mice Results in Delayed Lipid Clearance Following CNS Injury
by: Bridget Shafit-Zagardo, et al.
Published: (2023-06-01)

INTS8 accelerates the epithelial-to-mesenchymal transition in hepatocellular carcinoma by upregulating the TGF-β signaling pathway
by: Tong H, et al.
Published: (2019-02-01)

NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner
by: Hui Li, et al.
Published: (2020-07-01)